Jo Kitawaki

No ORCID on file · 109 papers in corpus · active 1989-2026

Study types

  • article 80
  • other 13
  • review 7
  • book-chapter 3
  • preprint 2

Condition tags

  • endometriosis 90
  • mesh:D004715 69
  • adenomyosis 24
  • endometrioma 19
  • infertility 9
  • dysmenorrhea 7
  • mesh:D004412 6
  • mesh:D017699 6
  • dyspareunia 3
  • die_deep_infiltrating 3
review 2026
Reproductive medicine and biology ·doi:10.1002/rmb2.70051

BACKGROUND: Endometriosis is increasingly recognized as a disorder of impaired reproductive immune tolerance rather than solely an endocrine disease. Although previous studies have reported inconsistent findings regarding the number of regu…

other 2026
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-025-02014-2
other 2025
Human Reproduction ·doi:10.1093/humrep/deaf054

STUDY QUESTION: Does the restoration of regulatory T cells (Tregs) suppress the progression of endometriosis? SUMMARY ANSWER: Adoptive transfer of Tregs suppresses the progression of endometriosis and reduces the levels of helper T (Th)-ce…

other 2025
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2025.2516202

OBJECTIVE: Endometriosis is an estrogen-dependent disease wherein isoflavones interact with estrogen receptors. Daidzein-rich isoflavone aglycones (DRIAs) have been shown to inhibit cell proliferation and aromatase activity in vitro and in …

other 2025
Trials ·doi:10.1186/s13063-025-08750-9

BACKGROUND: Endometriosis presents as endometrial tissue growths outside the uterine cavity with its major symptoms including dysmenorrhea and infertility. Progestin preparations, such as dienogest, are the first-line therapy for endometrio…

erratum 2024
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2024.02.004

The authors regret “We are very sorry for the careless printing mistake in the proper alignment of case numbers in Table 2, Table 3 of the mentioned article. These case numbers [(n = 25) and (n = 782)] should be read above the line and belo…

other 2024
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2023.12.033

OBJECTIVE: We examined the prevalence and risk factors in association with neonatal uterine bleeding (NUB) by retrospective search of contemporary and historical medical records and investigated the possible association between the history …

article 2023
Journal of reproductive immunology ·doi:10.1016/j.jri.2023.103825
article 2023
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-023-01099-1

BACKGROUND: It has been hypothesized that the origin of early-onset endometriosis could be from endometrial mesenchymal stem cells (eMSCs) in neonatal uterine blood (NUB). There is no information on the possible mechanistic basis linking an…

article 2023
Gynecology and minimally invasive therapy ·doi:10.4103/gmit.gmit_132_22

Objectives: The effects of laparoscopic surgical management in women with stage III/IV endometriosis remain controversial. The standard extent of resection for stage III/IV endometriosis with deep endometriosis to treat endometriosis-associ…

other 2023
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.13689

PROBLEM: Endometriosis is a proliferative disease characterized by cytokine-induced inflammation. The objective of this study was to assess cell growth and PGE2 production induced by TNF-α in endometriotic stromal cells (ESCs) in spheroid c…

preprint 2022
·doi:10.21203/rs.3.rs-1951340/v1
preprint 2022
·doi:10.21203/rs.3.rs-1951340/v2
article 2022
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2022.07.009
article 2022
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2022.2067329

PURPOSE: To collect real-world safety and clinical outcome data on the levonorgestrel-releasing intrauterine system (LNG-IUS) for functional/organic heavy menstrual bleeding (HMB) and dysmenorrhoea in Japanese women (J-MIRAI). MATERIALS AND…

article 2022
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15416

More than 10 years following the publication of "The General Rules for Clinical Management of Endometriosis: The second edition" in January 2010, the long-awaited third edition has arrived. The second edition represents the bible for endome…

article 2022
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-022-01089-5
article 2022
·doi:10.2139/ssrn.4201389
article 2022
The Journal of clinical endocrinology and metabolism ·doi:10.1210/clinem/dgac118

CONTEXT: Progesterone resistance including progesterone receptor (PR) deficiency contributes to the pathophysiology of endometriosis; however, whether the PR expression levels in ovarian endometrioma (OE) correlate with the postoperative re…

article 2022
Contraception ·doi:10.1016/j.contraception.2022.08.006

ObjectivesWe collected real-world data on the safety and clinical outcomes of the levonorgestrel-releasing intrauterine system (LNG-IUS) for heavy menstrual bleeding and dysmenorrhea.Study DesignThis was a prospective, multicenter, single-c…

rct 2022
Fertility and sterility ·doi:10.1016/j.fertnstert.2021.11.013

OBJECTIVE: To evaluate the efficacy and safety of 40-mg relugolix (REL) compared with those of leuprorelin (LEU) in women with endometriosis-associated pain. DESIGN: Phase 3, multicenter, randomized, double-blind, double-dummy, active-cont…

article 2022
·doi:10.1016/j.jri.2022.103696
article 2021
Reproductive medicine and biology ·doi:10.1002/rmb2.12391

PURPOSE: To assess the efficacy and safety of dydrogesterone in Japanese women with ovarian endometrioma in a real-world setting. METHODS: The post-marketing study involved 15 sites in Japan. Dydrogesterone 10 mg twice daily orally was admi…

article 2021
Human Reproduction ·doi:10.1093/humrep/deab090

STUDY QUESTION: Is there any change in the distribution of microvilli and microtubules in the apical endometria of women with adenomyosis? SUMMARY ANSWER: We observed microvilli damage in the apical endometria and an axonemal alteration cha…

article 2021
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.13498

PROBLEM: Despite abundant reports on the risk role of uterine outflow tract obstruction in endometriosis, information on the occurrence of endometriosis in women with Chlamydia trachomatis infection causing fallopian tube obstruction is unk…